• 6952 Citations
  • 39 h-Index
1977 …2017
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Maria Flavia Di Renzo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 24 Similar Profiles
Proto-Oncogene Proteins c-met Medicine & Life Sciences
Hepatocyte Growth Factor Medicine & Life Sciences
Oncogenes Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Osteosarcoma Medicine & Life Sciences
Fibroblasts Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1977 2017

  • 6952 Citations
  • 39 h-Index
  • 104 Article
10 Citations (Scopus)

Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF

Konda, J. D., Olivero, M., Musiani, D., Lamba, S. & Di Renzo, M. F., Jan 1 2017, In : Molecular Oncology. 11, 6, p. 599-611 13 p.

Research output: Contribution to journalArticle

HSP27 Heat-Shock Proteins
Epidermal Growth Factor Receptor
Oncogenes
Colorectal Neoplasms
Lamin Type B

Everolimus induces Met inactivation by disrupting the FKBP12/Met complex

Raimondo, L., D'Amato, V., Servetto, A., Rosa, R., Marciano, R., Formisano, L., di Mauro, C., Orsini, R. C., Cascetta, P., Ciciola, P., de Maio, A. P., di Renzo, M. F., Cosconati, S., Bruno, A., Randazzo, A., Napolitano, F., Montuori, N., Veneziani, B. M., de Placido, S. & Bianco, R., 2016, In : Oncotarget. 7, 26, p. 40073-40084 12 p.

Research output: Contribution to journalArticle

Tacrolimus Binding Protein 1A
Sirolimus
Everolimus
Neoplasms
Immunophilins
Ovarian Neoplasms
Neoplasm Metastasis
Fibronectins
MAP Kinase Signaling System
Protein-Serine-Threonine Kinases
3 Citations (Scopus)
Platinum
Phosphoric Monoester Hydrolases
Ovarian Neoplasms
Pharmaceutical Preparations
Hepatocyte Growth Factor
4 Citations (Scopus)

Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer

Erriquez, J., Olivero, M., Mittica, G., Scalzo, M. S., Vaira, M., De Simone, M., Ponzone, R., Katsaros, D., Aglietta, M., Calogero, R., Di Renzo, M. F. & Valabrega, G., May 1 2016, In : Oncotarget. 7, 18, p. 26181-26191 11 p.

Research output: Contribution to journalArticle

Precision Medicine
Ovarian Neoplasms
Drug Therapy
Heterografts
trabectedin